Oruka Therapeutics Inc.

NASDAQ: ORKA · Real-Time Price · USD
15.30
0.30 (2.00%)
At close: Aug 15, 2025, 12:35 PM

Oruka Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
27K 111K 114K 91K
Gross Profit
-27K -111K -114K -91K
Operating Income
-88.12M -7.3M -9.84M -19.34M
Interest Income
5.86M 1.96M 675K n/a
Pretax Income
-83.72M -5.34M -9.93M -19.32M
Net Income
-83.72M -5.34M -9.93M -19.32M
Selling & General & Admin
13.04M 6.17M 5.26M 5.41M
Research & Development
75.06M 1.01M 4.46M 13.83M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
88.1M 7.18M 9.73M 19.24M
Interest Expense
1.47M n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
88.12M 7.3M 9.84M 19.34M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
16.79M 14.42M 14.41M 13.9M
Shares Outstanding (Diluted)
16.79M 14.42M 14.41M 13.9M
EPS (Basic)
-4.99 -4.44 -8.27 -16.68
EPS (Diluted)
-4.99 -4.44 -8.27 -16.68
EBITDA
-82.23M -5.23M -9.81M -19.23M
EBIT
-82.26M -5.34M -9.93M -19.32M
Depreciation & Amortization
27K 111K 114K 91K